127 related articles for article (PubMed ID: 32408771)
1. Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection.
Dandachi D; Dang BN; Lucari B; Swindells S; Giordano TP
AIDS Care; 2021 Jun; 33(6):801-809. PubMed ID: 32408771
[TBL] [Abstract][Full Text] [Related]
2. Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya.
Kaggiah A; Maina CN; Kinuthia J; Barthold D; Hauber B; Tran J; Simoni JM; Graham SM
BMC Infect Dis; 2024 Apr; 24(1):415. PubMed ID: 38641565
[TBL] [Abstract][Full Text] [Related]
3. U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.
Graham SM; Barthold D; Hauber B; Brah AT; Saldarriaga E; Collier AC; Ho RJY; ; Marconi VC; Simoni JM
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26099. PubMed ID: 37439051
[TBL] [Abstract][Full Text] [Related]
4. Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study.
Massaroni V; Delle Donne V; Borghetti A; Ciccullo A; Lombardi F; Giuliano G; Farinacci D; Visconti E; Tamburrini E; Di Giambenedetto S
AIDS Patient Care STDS; 2022 May; 36(5):178-185. PubMed ID: 35507326
[TBL] [Abstract][Full Text] [Related]
5. Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV.
Barthold D; Saldarriaga EM; Brah AT; Hauber B; Banerjee P; Fuller SM; McCaslin D; Moldoveanu AM; Marconi VC; Simoni JM; Graham SM
AIDS; 2023 Aug; 37(10):1545-1553. PubMed ID: 37289570
[TBL] [Abstract][Full Text] [Related]
6. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.
Campbell CK; Kielhold K; Reynolds HE; Vincent W; Siconolfi DE; Ramos SD; Ogunbajo A; Kegeles SM; Storholm ED
Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791816
[TBL] [Abstract][Full Text] [Related]
7. "A dream come true": Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania.
Kerrigan D; Sanchez Karver T; Muraleetharan O; Savage V; Mbwambo J; Donastorg Y; Likindikoki S; Perez M; Gomez H; Mantsios A; Murray M; Beckham SW; Davis W; Galai N; Barrington C
PLoS One; 2020; 15(6):e0234666. PubMed ID: 32530939
[TBL] [Abstract][Full Text] [Related]
8. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
[TBL] [Abstract][Full Text] [Related]
9. The clinical role and cost-effectiveness of long-acting antiretroviral therapy.
Ross EL; Weinstein MC; Schackman BR; Sax PE; Paltiel AD; Walensky RP; Freedberg KA; Losina E
Clin Infect Dis; 2015 Apr; 60(7):1102-10. PubMed ID: 25583979
[TBL] [Abstract][Full Text] [Related]
10. Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review.
Sued O; Nardi N; Spadaccini L
Curr Opin HIV AIDS; 2022 May; 17(3):145-161. PubMed ID: 35439789
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
Mantsios A; Murray M; Karver TS; Davis W; Margolis D; Kumar P; Swindells S; Bredeek UF; García Del Toro M; Garcia Gasalla M; Rubio García R; Antela A; Hudson K; Griffith S; Kerrigan D
AIDS Behav; 2020 Dec; 24(12):3473-3481. PubMed ID: 32410051
[TBL] [Abstract][Full Text] [Related]
12. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
[TBL] [Abstract][Full Text] [Related]
13. Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
Mantsios A; Murray M; Karver TS; Davis W; Galai N; Kumar P; Swindells S; Bredeek UF; García RR; Antela A; Gomis SC; Bernáldez MP; Czarnogorski M; Hudson K; Walters N; Kerrigan D
BMC Health Serv Res; 2021 Mar; 21(1):255. PubMed ID: 33743684
[TBL] [Abstract][Full Text] [Related]
14. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
Endebu T; Deksisa A; Dugasa W; Mulu E; Bogale T
BMC Public Health; 2019 Oct; 19(1):1315. PubMed ID: 31638936
[TBL] [Abstract][Full Text] [Related]
15. Supernatural Explanatory Models of Health and Illness and HIV Antiretroviral Therapy Use Among Young Men Who Have Sex with Men in China.
Pan SW; Smith MK; Carpiano RM; Fu H; Ong JJ; Huang W; Tang W; Tucker JD
Int J Behav Med; 2020 Oct; 27(5):602-608. PubMed ID: 32415590
[TBL] [Abstract][Full Text] [Related]
16. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study.
Ishihara M; Hikasa S; Tsukiji M; Kunimoto Y; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kashiwabara Y; Fujii K; Shimabukuro S; Watanabe D; Tsurumi H; Suzuki A
AIDS Res Ther; 2023 Aug; 20(1):62. PubMed ID: 37641099
[TBL] [Abstract][Full Text] [Related]
17. Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid - the Gothenburg HIV CSF Study Cohort.
Hagberg L; Gisslén M
BMJ Open; 2023 May; 13(5):e070693. PubMed ID: 37197824
[TBL] [Abstract][Full Text] [Related]
18. Are Anal Sex Roles Associated with Preferences for Pre-Exposure Prophylaxis Administration Modalities Among Men Who Have Sex with Men?
Goedel WC; Schneider JA; Hambrick HR; Kreski NT; Morganstein JG; Park SH; Mgbako O; Duncan DT
Arch Sex Behav; 2018 Oct; 47(7):2123-2133. PubMed ID: 29192368
[TBL] [Abstract][Full Text] [Related]
19. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
[TBL] [Abstract][Full Text] [Related]
20. "What Is the Benefit?": Perceptions and Preferences for Long-Acting Injectable Antiretroviral Therapy Among People Living With HIV.
Rodriguez Gonzalez H; Volcan AI; Castonguay BJU; Carda-Auten J; Ruiz C; Peretti M; Suarez A; Kerrigan D; Wohl DA; Barrington C
AIDS Educ Prev; 2023 Dec; 35(6):467-483. PubMed ID: 38096455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
